Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy
Page 1 of 1
Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy
Vieira NM, Spinazzola JM, Alexander MS, Moreira YB, Kawahara G, Gibbs DE, Mead LC, Verjovski-Almeida S, Zatz M, Kunkel LM. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy. PNAS USA. 2017;[Epub ahead of print] doi: 10.1073/pnas.1703556114
Similar topics
» The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy
» Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics
» CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
» NAD+ Biosynthesis Ameliorates a Zebrafish Model of Muscular Dystrophy
» Eteplirsen for the treatment of duchenne muscular dystrophy
» Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics
» CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
» NAD+ Biosynthesis Ameliorates a Zebrafish Model of Muscular Dystrophy
» Eteplirsen for the treatment of duchenne muscular dystrophy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum